文献速递艾滋病与性传播感染

HIV感染者侵袭性肛门癌的临床预测因素与结局:一项起始队列研究

Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort.
PubMed 文献 · Clin Infect Dis · 2024-01-01

本研究利用美国加州大学圣地亚哥分校2006年11月30日至2021年3月3日的肛门癌筛查起始队列,共8139名HIV感染者,其中4105人接受筛查并中位随访5.5年,33人发生侵袭性肛门癌。初始或随访细胞学显示肛门高级别鳞状上皮内病变(aHSIL)者风险比为4.54,CD4最低值≤200/µL者风险比为2.99,两者联合风险增加9倍。33例癌症患者中12人死亡,其中7人(21%)死于癌症进展,这些死者初诊时临床分期为IIIA或更高。

要点

  • HIV感染者中,aHSIL和CD4最低值≤200/µL是侵袭性肛门癌的独立预测因素。
  • 同时具有aHSIL和CD4最低值≤200/µL者,5年和10年侵袭性肛门癌概率分别为3.40%和4.27%。
  • 死于癌症进展者初诊时均为临床分期IIIA或更高,凸显早期诊断的重要性。

核心结论

  • 同时具有aHSIL和CD4最低值≤200/µL的HIV感染者侵袭性肛门癌风险最高。
  • 死于侵袭性肛门癌进展者诊断时均为临床分期IIIA或更高,凸显通过高分辨率肛门镜筛查实现早期诊断的重要性。

研究设计与样本

  • 研究为纵向起始队列,评估肛门癌筛查中的风险因素和侵袭性肛门癌发生概率,采用Cox模型。
  • 筛查包括肛门细胞学和数字直肠指检,任一结果异常则行高分辨率肛门镜。
  • 2006年11月30日至2021年3月3日期间,加州大学圣地亚哥分校共8139名HIV感染者接受诊疗,其中4105人接受筛查并中位随访5.5年。
  • 随访期间33人发生肛门癌。

主要发现

  • 初始或后续随访细胞学显示aHSIL者发生侵袭性肛门癌的风险比为4.54。
  • CD4最低值≤200/µL者发生侵袭性肛门癌的风险比为2.99。
  • aHSIL和CD4最低值≤200/µL的联合效应使侵袭性肛门癌风险较两者均无时增加9倍。
  • 时间更新细胞学aHSIL且CD4细胞计数≤200/µL的HIV感染者,5年和10年侵袭性肛门癌概率分别为3.40%和4.27%。
  • 33例癌症患者中12人死亡,其中7人(占33例的21%)死于癌症进展,这些死者初诊时临床分期为IIIA或更高。

关键数值与推荐

  • aHSIL(初始或后续随访细胞学)预测侵袭性肛门癌的风险比4.54。
  • CD4最低值≤200/µL预测侵袭性肛门癌的风险比2.99。
  • aHSIL和CD4最低值≤200/µL联合使侵袭性肛门癌风险增加9倍(与两者均无相比)。
  • 时间更新细胞学aHSIL且CD4细胞计数≤200/µL者,5年侵袭性肛门癌概率3.40%,10年概率4.27%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Due to the heterogeneity of risk for invasive anal cancer (IAC) among people with human immunodeficiency virus (PWH), we investigated predictors of IAC and described outcomes among those with a cancer diagnosis. METHODS: Using a longitudinal inception cohort of anal cancer screening, we evaluated risk factors and outcome probabilities for incident IAC in Cox models. Screening included anal cytology and digital anorectal examination, and, if results of either were abnormal, high-resolution anoscopy. RESULTS: Between 30 November 2006 and 3 March 2021, a total of 8139 PWH received care at the University of California, San Diego, with 4105 individuals undergoing screening and subsequently followed up over a median of 5.5 years. Anal cancer developed in 33 of them. IAC was more likely to develop in patients with anal high-grade squamous intraepithelial lesions (aHSILs) on initial or subsequent follow-up cytology (hazard ratio, 4.54) and a nadir CD4 cell count ≤200/µL (2.99). The joint effect of aHSILs and nadir CD4 cell count ≤200/µL amplified the hazard of IAC by 9-fold compared with the absence of both. PWH with time-updated cytology aHSIL and CD4 cell counts ≤200/µL had 5- and 10-year probabilities of IAC of 3.40% and 4.27%, respectively. Twelve individuals with cancer died, 7 (21% of the total 33) due to cancer progression, and they had clinical stage IIIA or higher cancer at initial diagnosis. CONCLUSIONS: PWH with both aHSIL and a nadir CD4 cell count ≤200/µL have the highest risk of IAC. PWH who died due to IAC progression had clinical stage IIIA cancer or higher at diagnosis, highlighting the importance of early diagnosis through high-resolution anoscopic screening.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Cachay ER, Gilbert T, Qin H, et al. Clinical Predictors and Outcomes of Invasive Anal Cancer for People With HIV in an Inception Cohort. Clin Infect Dis. 2024. PMID: 38573010. doi:10.1093/cid/ciae124

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。